We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Aural ECG Device Diagnoses Heart Sounds

By HospiMedica International staff writers
Posted on 21 Aug 2017
A non-invasive, radiation-free acoustic electrocardiogram (ECG) device helps physicians detects both physiological and pathological heart murmurs.

The AUM Cardiovascular (Northfield, MN, USA) CADence device is a portable tool to diagnose valvular heart disease, congestive heart failure (CHF), and obstructive coronary artery disease; it can also be used to assess and track native, transcatheter, bioprosthetic, and mechanical heart valve function remotely. The device requires minimal training for operation and records audio turbulence signals from within the coronary arteries at four thorax wall locations. The turbulence is identified using a proprietary algorithm built into the device.

Image: An electronic listening device detects cardiovascular disease (Photo courtesy of AUM Cardiovascular).
Image: An electronic listening device detects cardiovascular disease (Photo courtesy of AUM Cardiovascular).

Data is then uploaded via Bluetooth to a tablet and analyzed by proprietary analytics engine. The results are available on the tablet itself and are also sent to a centralized email address for immediate report generation, long-term assessment, and record keeping, either in the electronic health record (HER) or printed for the patient chart. Audio data files can also be listened to directly on the tablet using earbuds. Testing can be conducted in less than 20 minutes, with diagnostic results available in minutes, thus avoiding long waits or lengthy testing protocols and possible follow-up appointments.

“If a patient does not have significant obstructive coronary artery disease, the CADence System will be able to confirm this approximately 9 out of 10 times,” said Marie Johnson, CEO of AUM Cardiovascular. “This efficient, noninvasive and reusable device has a lower safety risk profile than other diagnostic screening tests such as such as nuclear stress testing, computed tomography, and angiography.”

“The CADence system has the potential to dramatically enhance our ability to rule-out significant coronary artery disease and efficiently triage patients needing additional testing,” said interventional cardiologist Jay Thomas, MD, of Harbor-UCLA Medical Center (Los Angeles, CA, USA). “It is a rapid, cost-effective, radiation-free way to evaluate selected patients with chest pain. The need for something like CADence is quite obvious, considering how we have managed chest pain testing for the last twenty years.”

Related Links:
AUM Cardiovascular


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Multilevel Self-Loading Stretcher
CARRERA XL

Latest Critical Care News

AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases

Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time

Wearable Multiplex Biosensors Could Revolutionize COPD Management